Home Tags Auristatin F hydroxypropylamide

Tag: auristatin F hydroxypropylamide

Immunocapture-liquid Chromatography/Mass Spectrometry in Simultaneous Quantification of Total Antibody and ADC...

XMT-1522, an investigational antibody-drug conjugate (ADC) being developed by Mersana Therapeutics and Takeda, represents the first Dolaflexin®-based, cleavable ADC with a high drug-antibody ratio...

Mersana Presents Updated Data about its Dolasynthen Platform and Synthemer Scaffold

Clinical-stage bio-pharmaceutical company, Mersana Therapeutics, presented preclinical data from the company's proprietary Dolasynthen platform and its modular Synthemer scaffold during the 2019 Annual Meeting...

FEATURED RESOURCES